CVS Health also has been proactively informing members and patients about the benefits of both the Specialty Connect and Specialty Expedite programs to improve care.
Large insurers are implementing policies requiring health care providers to get provider-administered therapies from specialty pharmacies
Home infusion specialty services have been positioned for expansion into chemotherapy as they have been integrating into payer infrastructures over time
Omnicare, which serves more than one million patients per year, has been a drag on CVS Health’s financial results since its acquisition
Aetna’s new designs, called Upfront Advantage and Flexible Five, offer members coverage for some preventive services before they meet deductibles
Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers
Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs
Continuing weak margins due to staffing struggles, recent generic introductions, and decreasing reimbursements remain the leading drivers of the poor results